Completed PHASE4 INTERVENTIONAL 2-arm NCT00133237

Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)

Prospective, Randomized Trial of the Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease(ISAR-LEFT-MAIN)

Sponsor: Deutsches Herzzentrum Muenchen

Conditions Coronary Disease

Interventions Paclitaxel-eluting stent Sirolimus-eluting stent

Updated 6 times since 2017 Last updated: Mar 12, 2010 Started: Jul 31, 2005 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Disease, this trial is completed. The trial is conducted by Deutsches Herzzentrum Muenchen and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Nov 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Nov 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deutsches Herzzentrum Muenchen
Technical University of Munich

Data source: Deutsches Herzzentrum Muenchen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany